Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04805112
Other study ID # 848410
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2021
Est. completion date July 2, 2021

Study information

Verified date July 2022
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled trial will assess the feasibility, acceptability and impact of the provision of multiple oral-fluid based HIV self-test kits to HIV-negative adolescents aged 15-19 years to promote HIV testing among their sexual partners and couples testing.


Description:

This study will recruit HIV-negative adolescents girls (AG) aged 15-19 years in Siaya County, western Kenya. The study will evaluate the impact of the provision of oral HIV self-testing on uptake of testing among partners of adolescent girls. We will randomize about 300 sexually active AG to either an intervention group that receives multiple oral self-test kits that they can choose to offer to their sexual partner(s) or to a control group that will be given multiple referral coupons that their partners can use for HIV testing at pre-selected HIV testing services (HTS) sites. We will collect data on whether the kits were offered, to whom they were offered, if they were accepted, if they were used and with what results, if known, and if the partners who obtained HIV-positive results sought confirmatory testing. We will also conduct in-depth interviews with a sub-set adolescents to explore their experiences in offering HIV self-testing to their male partners. This study has 4 specific aims: i) determine whether adolescent girls can safely offer oral HIV self-tests to their partners; ii) assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls; iii) document adverse events associated with offering oral self-testing to sexual partners of adolescent girls; and iv) qualitatively explore the experiences of adolescent girls when offering self-test kits to their partners.


Recruitment information / eligibility

Status Completed
Enrollment 349
Est. completion date July 2, 2021
Est. primary completion date April 19, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 19 Years
Eligibility Inclusion Criteria: - Female - Aged 15-19 years - HIV-negative (willing to self-test onsite in the presence of the Research Assistant who is also a trained HIV counselor) - Has at least one current sexual partner she expects to meet at least twice in the next 3 months (not necessarily to have sex); this will provide opportunity for the participant to suggest/offer testing. - Resides in Siaya County and does not intend to relocate within 6 months from enrollment, to allow follow up to be completed and to conduct IDI with those selected. - Willing to be randomized into the partner self-testing or HTS referral groups. - Reporting no incident of sexual, physical, emotional, or economic abuse in the last 12 months from the partner she intends to offer (Appendix 4) or refer for testing (Appendix 3) in the next 3 months and does not believe the partner will abuse her if she offers the self-test kits or HTS referral coupon. - Has a male partner who has not tested for 6 months or whose HIV status is unknown to her. - Agrees to give consent to participate in the study. Exclusion Criteria: - Male - HIV-positive - Not willing to self-test onsite under in the presence of the Research Assistant - Aged <15 years or >19 years - Does not have a current sexual partner or does not expect to meet the partner at least twice in the next 3 months - Does not reside in Siaya County or intends to relocate within the next 6 months - Not interested in obtaining HIV self-tests or HTS referral coupon for purposes of suggesting testing to their sexual partners - Reporting an incidence of sexual, physical, emotional or economic abuse in the last 12 months from the partner she would have offered self-test kit or referred for testing, or believes the partner may subject her to sexual, physical, emotional, or economic abuse if she offered them self-test kit or HTS coupon. - Has a male partner who tested within the last 6 months. - Does not give consent to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Provision of multiple self-tests
Participants will be given multiple Oraquick Advance HIV-1/2 test kits to distribute to their sexual partners for partner testing or couple testing. Phone interviews will be conducted with the participants to assess whether they provided a HIV self-test to their partner, if the test was used, how it was used (partner testing or couple testing), if the partner disclosed his results, the partner's reaction to the results, and if the partner went for confirmatory testing

Locations

Country Name City State
Kenya Impact Research & Development Organization Kisumu

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Impact Research & Development Organization, National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary uptake of partner HIV testing proportion of partners that complete HIV testing 3 months
Secondary Introduce testing proportion of participants who introduce testing to their partners 3 months
Secondary Partner accept testing proportion of partners who were offered HIVST or referral coupon and accepted 3 months
Secondary Partner testing proportion of participants who report their partner tested alone 3 months
Secondary Couples testing proportion of participants who report testing with their partner 3 months
Secondary Positive partner proportion of participants who report their partner test result was positive 3 months
Secondary linked to care Proportion of participants who report their partners was linked to care 3 months
Secondary Intimate partner violence proportion of participants in each study group who report intimate partner violence related to HIV testing 3 months
Secondary Confirmatory testing for positive HIV self-test proportion of participants in the intervention group who report their partner tested positive and went for confirmatory testing 3 months
See also
  Status Clinical Trial Phase
Terminated NCT03516318 - Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria N/A
Completed NCT04653194 - Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat' Phase 3
Completed NCT01792570 - DRV/r + RPV QD: Efficacy and Toxicity Reduction Phase 3
Active, not recruiting NCT04826562 - Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND) Phase 4
Completed NCT04191967 - Thermocoagulation for Treatment of Precancerous Cervical Lesions N/A
Completed NCT02919306 - Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults Phase 1/Phase 2
Completed NCT02812329 - Intervention to Encourage HIV Testing and Counseling Among Adolescents Phase 1
Completed NCT02651376 - Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients Phase 1/Phase 2
Completed NCT02516930 - A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China N/A
Recruiting NCT02392884 - HIV Medication Adherence in Underserved Populations N/A
Completed NCT01944371 - Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study Phase 1/Phase 2
Recruiting NCT01778374 - Mater-Bronx Rapid HIV Testing Project. N/A
Completed NCT00914225 - Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya N/A
Completed NCT01490346 - Tissue Drug Levels of HIV Medications N/A
Completed NCT01460433 - Problems With Immune Recovery in the Gut Tissue N/A
Completed NCT01076179 - Kaletra in Combination With Antiretroviral Agents N/A
Completed NCT00317460 - Buprenorphine and Integrated HIV Care Phase 4
Terminated NCT04240210 - Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) Phase 4
Active, not recruiting NCT04704336 - Integration of Hypertension Management Into HIV Care in Nigeria N/A
Completed NCT03254277 - 3BNC117-LS First-in-Human Phase 1 Study Phase 1